Manning & Napier Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $96M | Sell |
|
|||||
|
2023
Q4 | $96.6M | Sell |
|
|||||
|
2023
Q3 | $86.6M | Sell |
|
|||||
|
2023
Q2 | $90.3M | Sell |
|
|||||
|
2023
Q1 | $83.3M | Sell |
|
|||||
|
2022
Q4 | $78.5M | Sell |
|
|||||
|
2022
Q3 | $80.2M | Sell |
|
|||||
|
2022
Q2 | $78.9M | Sell |
|
|||||
|
2022
Q1 | $181M | Sell |
|
|||||
|
2021
Q4 | $192M | Buy |
|
|||||
|
2021
Q3 | $158M | Sell |
|
|||||
|
2021
Q2 | $181M | Buy |
|
|||||
|
2021
Q1 | $184M | Buy |
|
|||||
|
2020
Q4 | $92.7M | Buy |
|
|||||
|
2020
Q3 | $15.5M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Buy |
|
|||||
|
2020
Q1 | $12.7M | Sell |
|
|||||
|
2019
Q4 | $48M | Sell |
|
|||||
|
2019
Q3 | $40.3M | Sell |
|
|||||
|
2019
Q2 | $70.3M | Buy |
|
|||||
|
2019
Q1 | $55.3M | Sell |
|
|||||
|
2018
Q4 | $55.1M | Sell |
|
|||||
|
2018
Q3 | $67.7M | Sell |
|
|||||
|
2018
Q2 | $61.5M | Buy |
|
|||||
|
2018
Q1 | $58.3M | Sell |
|
|||||
|
2017
Q4 | $135M | Buy |
|